EGLN2 and colitis: In this context, our group previously showed that haematopoietic deletion of Phd1 is both necessary and sufficient to protect against experimental colitis, which relies, at least in part, on the promotion of macrophages to the anti-inflammatory M2 phenotype [10,11].